Prime Medicine, Inc.
PRME
Revenue
0.00
▼-591.00k▼-100.00%
3 Months ChangeAssets
259.71M
▼-51.68M▼-16.60%
3 Months ChangeLiabilities
63.12M
▼-4.50M▼-6.66%
3 Months ChangeFree Cash Flow
-70.03M
▼-26.47M▼-60.77%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0001628280-24-043500
2024-09-30
Form 8-K
ID: 0001628280-24-041541
2024-08-08
Form 10-Q
ID: 0001628280-24-035893
2024-08-08
Form 8-K
ID: 0001628280-24-035886
2024-06-12
Form 8-K
ID: 0001628280-24-027816
2024-05-21
Form 8-K
ID: 0001628280-24-024530
2024-05-10
Form 10-Q
ID: 0001628280-24-022473
2024-05-10
Form 8-K
ID: 0001628280-24-022466
2024-03-01
Form 8-K
ID: 0001628280-24-008113
2024-02-16
Form 8-K
ID: 0001193125-24-038016